Inflammation in Children With Attention-Deficit/Hyperactivity Disorder (ADHD_CYTO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00391495|
Recruitment Status : Unknown
Verified August 2006 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Not yet recruiting
First Posted : October 24, 2006
Last Update Posted : June 19, 2007
|Condition or disease||Intervention/treatment|
|Attention-Deficit/Hyperactivity Disorder||Procedure: Blood drawing|
Attention deficit-hyperactivity disorder (ADHD) is a prevalent childhood neuropsychiatric disorder, characterized by age-inappropriate and impairing levels of inattention, hyperactivity and impulsiveness. Approximately 5-10% of school-age children are affected by ADHD, and in many cases, symptoms persist into adolescence and adulthood.
Cytokines are key mediators of immune function and can be either pro-inflammatory or anti-inflammatory. Recently few studies have suggested involvement of cytokine pathways in subjects with ADHD.
Polymorphism of IL-1 receptors antagonists' alleles have been suggested in families and subjects suffering from ADHD. Moreover, a new variant of inflammatory bowel disease, another immunological based disease, was recently suggested in children with ADHD and other developmental disorders. There are no other published reports on cytokine production in children who suffer from ADHD.
|Study Type :||Observational|
|Estimated Enrollment :||45 participants|
|Observational Model:||Case Control|
|Official Title:||Inflammation in Children With Attention-Deficit/Hyperactivity Disorder|
|Study Start Date :||September 2007|
|Estimated Study Completion Date :||December 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00391495
|Contact: Nachum Vaisman, Prof. (MD)||email@example.com|
|The Unit of Clinical Nutrition||Not yet recruiting|
|Tel Aviv, Israel|
|Contact: Nachum Vaisman, Prof. +972-524-266-596 firstname.lastname@example.org|
|Principal Investigator: Nachum Vaisman, Prof.|
|Principal Investigator:||Nachum Vaisman, Prof. (MD)||Tel-Aviv Sourasky Medical Center|